Top 10 Companies in the Global Trypsin EDTA Solution Market (2026): Market Leaders Powering Cell Culture Innovation

In Business Insights
June 16, 2026

MARKET INSIGHTS

Global Trypsin EDTA Solution Market was valued at USD 180 million in 2024. The market is projected to grow from USD 190 million in 2025 to USD 290 million by 2032, exhibiting a CAGR of 5.4% during the forecast period.

Trypsin EDTA Solution is a critical reagent in cell culture applications, combining the proteolytic enzyme trypsin, a serine protease that hydrolyzes proteins to detach adherent cells from surfaces, with EDTA, a chelating agent that disrupts cell adhesion by binding calcium and magnesium ions. This solution is widely used in biotechnology and life sciences for subculturing cells, facilitating processes like cell passaging, harvesting, and maintaining cell lines in research and industrial settings.

The market is experiencing steady growth driven by expanding biotechnology and pharmaceutical sectors, rising demand for cell‑based therapies, and advancements in tissue engineering. Furthermore, increased investments in regenerative medicine and vaccine development are boosting usage. Key players such as Thermo Fisher Scientific, Sigma‑Aldrich (Merck), and STEMCELL Technologies dominate with innovative portfolios, including optimized formulations for enhanced cell viability.

Global Trypsin EDTA Solution Market – View in Detailed Research Report


🔟 1. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: High‑purity Trypsin EDTA solutions for academic, industrial, and GMP‑grade applications

Thermo Fisher Scientific remains the dominant manufacturer of Trypsin EDTA solutions, providing both standard‑grade (0.05 M, 0.1 M) and customized concentrations for large‑scale pharmaceutical and academic laboratories. Their integrated supply chain, global distribution network, and ongoing investment in GMP‑certified production facilities give them a decisive market‑share advantage.

Sustainability Initiatives:

  • Investment in green chemistry to reduce solvent usage
  • Development of animal‑free, recombinant trypsin formulations
  • Commitment to carbon‑neutral manufacturing by 2030

9️⃣ 2. Sigma‑Aldrich (Merck)

Headquarters: Darmstadt, Germany
Key Offering: Broad portfolio of Trypsin EDTA solutions, including cell‑type‑specific formulations

Sigma‑Aldrich (Merck) supplies a wide range of Trypsin EDTA solutions for research and industrial use, emphasizing high purity and consistency. Their focus on product innovation and robust quality control has made them a preferred supplier in academia and biopharma.

Sustainability Initiatives:

  • Adoption of biodegradable packaging for reagents
  • Implementation of waste‑reduction protocols in manufacturing
  • Support for animal‑free reagent development

8️⃣ 3. STEMCELL Technologies

Headquarters: Vancouver, Canada
Key Offering: GMP‑certified Trypsin EDTA line optimized for stem‑cell culture

STEMCELL Technologies focuses on regenerative‑medicine applications, offering a GMP‑certified Trypsin EDTA line that preserves stem‑cell viability and differentiation potential. Their products are widely used in cell‑therapy manufacturing and research.

Sustainability Initiatives:

  • Development of serum‑free, chemically defined formulations
  • Partnerships with academic institutions for green reagent research
  • Carbon‑offset programs for product logistics

7️⃣ 4. HiMedia Laboratories

Headquarters: Mumbai, India
Key Offering: Cost‑effective bulk Trypsin EDTA solutions for emerging markets

HiMedia Laboratories provides affordable, high‑quality Trypsin EDTA solutions tailored to the growing biopharma and research sectors in India and Southeast Asia. Their focus on scalability and price competitiveness has expanded their market reach.

Sustainability Initiatives:

  • Implementation of energy‑efficient manufacturing processes
  • Use of renewable energy sources in production facilities
  • Support for local regulatory compliance and GMP training

6️⃣ 5. Biological Industries

Headquarters: Ramat Gan, Israel
Key Offering: Cell‑type‑specific Trypsin EDTA formulations with proprietary stabilizers

Biological Industries offers a range of Trypsin EDTA solutions designed for immunology and regenerative‑medicine research, featuring proprietary stabilizers that enhance enzyme activity and shelf life.

Sustainability Initiatives:

  • Development of animal‑free, recombinant enzyme alternatives
  • Adoption of eco‑friendly packaging materials
  • Participation in regional sustainability certification programs

5️⃣ 6. PromoCell GmbH

Headquarters: Göttingen, Germany
Key Offering: Cell‑type‑specific Trypsin EDTA solutions with proprietary stabilizers for immunology

PromoCell GmbH specializes in formulations tailored to specific cell types, offering high‑performance Trypsin EDTA solutions that meet stringent research and GMP requirements.

Sustainability Initiatives:

  • Use of renewable energy in manufacturing plants
  • Implementation of closed‑loop water recycling systems
  • Collaboration with academic partners on green reagent development

4️⃣ 7. Beyotime Biotechnology

Headquarters: Shanghai, China
Key Offering: Cost‑effective bulk Trypsin EDTA solutions for emerging markets

Beyotime Biotechnology supplies high‑quality Trypsin EDTA solutions at competitive prices, targeting the rapidly expanding biopharma and research markets in Asia.

Sustainability Initiatives:

  • Transition to renewable energy sources in production
  • Reduction of single‑use plastic packaging
  • Support for local GMP certification programs

3️⃣ 8. Yeasen Biotech

Headquarters: Shanghai, China
Key Offering: Diverse portfolio of Trypsin EDTA solutions for academic and industrial use

Yeasen Biotech offers a broad range of Trypsin EDTA solutions, focusing on product quality, consistency, and regulatory compliance to meet the needs of both academia and biopharma.

Sustainability Initiatives:

  • Development of animal‑free recombinant trypsin alternatives
  • Implementation of waste‑reduction and recycling programs
  • Commitment to ISO 14001 environmental management standards

2️⃣ 9. Bio‑Rad Laboratories

Headquarters: Hercules, California, USA
Key Offering: High‑purity Trypsin EDTA solutions for research and industrial applications

Bio‑Rad Laboratories supplies a range of Trypsin EDTA solutions that meet the rigorous standards of academic research and biopharma manufacturing, emphasizing purity and batch consistency.

Sustainability Initiatives:

  • Use of bio‑based solvents in production processes
  • Reduction of carbon footprint through optimized logistics
  • Support for animal‑free reagent development

1️⃣ 10. VWR International

Headquarters: Radnor, Pennsylvania, USA
Key Offering: Wide array of Trypsin EDTA solutions for research, diagnostics, and industrial use

VWR International provides a comprehensive catalog of Trypsin EDTA solutions, catering to diverse user groups from academic laboratories to biopharma manufacturers.

Sustainability Initiatives:

  • Implementation of green packaging initiatives
  • Energy‑efficient manufacturing practices
  • Carbon‑neutral shipping options for global customers

Download FREE Sample Report


Get Full Report


Outlook: The Future of Trypsin EDTA Solution Market

The Trypsin EDTA Solution market is poised for continued expansion, driven by the rapid growth of biopharmaceutical manufacturing, increasing adoption of automated cell‑culture systems, and the shift toward animal‑free, recombinant enzyme alternatives. Regulatory frameworks will continue to shape product development, pushing manufacturers toward higher purity standards and sustainable production methods.


Future Trends Shaping the Market

  • Development of chemically defined, serum‑free Trypsin EDTA formulations to support GMP‑compliant cell therapies.
  • Integration of Trypsin EDTA solutions into digital bioprocess monitoring platforms for real‑time quality control.
  • Expansion of automated cell‑culture workflows, increasing demand for standardized, reproducible reagents.
  • Growth of emerging markets in Asia‑Pacific and Latin America, driven by local biopharma investment.
  • Continued focus on sustainability, including green chemistry and biodegradable packaging.